NCT02624037View on ClinicalTrials.gov

Precision IFX: Using a Dashboard to Individualize Infliximab Dosage

NACompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

October 21, 2020

Study Completion Date

October 21, 2020

Conditions
Inflammatory Bowel Disease
Interventions
OTHER

Individualized Dosage Precision IFX Dashboard

Pharmacokinetic Dashboard Recommended Dosage and Dosing Frequency of Infliximab

Trial Locations (1)

10029

Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, New York

Sponsors

Collaborators (1)

Prometheus Laboratories
All Listed Sponsors
collaborator

Prometheus Laboratories

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER